Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
The move signals a major expansion in access to next-generation weight-loss therapies
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
Subscribe To Our Newsletter & Stay Updated
